-
Danaher has been in China for 15 years and continues to increase its size in China's large market
Time of Update: 2023-01-06
Danaher Group, an innovator in global science and technology, participated in the Expo for the fifth time, and held its 15th anniversary celebration and opening ceremony in China with the theme of "Danhua 15 Years, Creating a New Era", releasing a number of local achievements of the "Ascend China" strategy, with special emphasis on continuously increasing the Chinese market and helping a healthy China.
-
Shanghai Hehuang Pharmaceutical was awarded the "National Harmonious Labor Relations Creation Model Enterprise"
Time of Update: 2023-01-06
62em; font-family:"Arial"; color:black; margin:0in; } SHANGHAI, Nov. 10, 2022 /PRNewswire/ -- On the afternoon of November 9, Lu Ying, director of the Human Resources and Social Security Bureau of Fengxian District, Shanghai, and Lu Baowen, deputy director of the bureau, came to the R&D and production base of Shanghai Hehuang Pharmaceutical Fengpu and sent the bronze medal and honor book of "National Harmonious Labor Relations Creation Demonstration Enterprise" to the company.
-
TD Biologics announces the latest advances in the clinical trial of CFI-402411, a first-of-its-kind HPK1 inhibitor, at the 2022 STIC Annual Meeting
Time of Update: 2023-01-06
1/2study: Hematopoietic Progenitor Kinase-1(HPK1)InhibitorCFI-402411as a Single Agent and in Combination with Pembrolizumab for the Treatment of Subjects with Advanced Solid MalignanciesAbout CFI-402411 CFI-402411 is a highly potent HPK1inhibitor that has been shown to have immunoactivating effects including mitigating inhibitory effects on T cell receptors (TCRs), disrupting abnormal expression of cytokines, and altering the tumor immunosuppressive environment through effector cells (i.
-
Merck's PD-1 inhibitor KEYTRUDA (R) was approved for a new indication for the treatment of triple-negative breast cancer in China
Time of Update: 2023-01-06
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
The State Food and Drug Administration conditionally approved the marketing of Linplisset tablets
Time of Update: 2023-01-06
The listing of this drug provides a treatment option for adult patients with relapsed and refractory follicular lymphoma after treatment with existing treatments.
The listing of this drug provides a treatment option for adult patients with relapsed and refractory follicular lymphoma after treatment with existing treatments.
-
Danaher has been in China for 15 years and continues to increase its size in China's large market
Time of Update: 2023-01-06
Danaher Group, an innovator in global science and technology, participated in the Expo for the fifth time, and held its 15th anniversary celebration and opening ceremony in China with the theme of "Danhua 15 Years, Creating a New Era", releasing a number of local achievements of the "Ascend China" strategy, with special emphasis on continuously increasing the Chinese market and helping a healthy China.
-
TD Biologics announces the latest advances in the clinical trial of CFI-402411, a first-of-its-kind HPK1 inhibitor, at the 2022 STIC Annual Meeting
Time of Update: 2023-01-06
1/2study: Hematopoietic Progenitor Kinase-1(HPK1)InhibitorCFI-402411as a Single Agent and in Combination with Pembrolizumab for the Treatment of Subjects with Advanced Solid MalignanciesAbout CFI-402411 CFI-402411 is a highly potent HPK1inhibitor that has been shown to have immunoactivating effects including mitigating inhibitory effects on T cell receptors (TCRs), disrupting abnormal expression of cytokines, and altering the tumor immunosuppressive environment through effector cells (i.
-
Bect Medical brought a number of debut exhibits to the 5th CIIE, and the innovation ecology helped healthy China
Time of Update: 2023-01-06
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Fujifilm participated in the 14th East-West Small Animal Clinical Veterinarian Conference 2022
Time of Update: 2023-01-06
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
The 2022 academic annual meeting of the Hematology Professional Committee of the China Association of Non-public Medical Institutions was successfully held
Time of Update: 2023-01-06
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Abbott and authoritative media release "2022 Diabetes Nutrition Cognitive Consumer Insights"
Time of Update: 2023-01-06
com Health Nutrition and Wellness Business Unit As one of the major chronic diseases, publicity and education, diet control, exercise therapy, drug treatment and blood glucose monitoring are the "five carriages" of diabetes prevention and management, and diet, as a component closely related to daily life, will directly affect blood sugar control and disease development, and is an important concern of diabetic patients 。 Yang Ye, vice president of JD.
-
Junshi Biologics announced that it has submitted a marketing authorization application for teripulimab to the UK Medicines and Healthcare Products Administration
Time of Update: 2023-01-05
Dr. Patricia Keegan, Chief Medical Officer of Junshi Biologics, said, "This month, we submitted our marketing applications for teripulimab to two major European regulatory agencies, which reflects the company's strong determination and efficient execution to promote innovative drugs for the benefit of patients around the world.
-
Benchmark Medical initiates U.S.-registered clinical trial of bladder cancer early detection product UriFind
Time of Update: 2023-01-05
62em; font-family:"Arial"; color:black; margin:0in; } First patient enrollment has been completed GUANGZHOU, Nov. 24, 2022 /PRNewswire/ -- Benchmark Medical announced that it has launched a registered clinical trial of its bladder cancer early detection product UriFind® in the United States and recently completed the enrollment of its first patient.
-
The first guest lineup is released! The first vaccine event in 2023 has set off another boom in new vaccine research and development!
Time of Update: 2023-01-05
com 【Free Attendance】 Click the link to receive a free ticket: _istranslated="1"> (only available to research institutions/vaccine, pharmaceutical R&D and manufacturing enterprises) For details of sponsorship/speech/participation/media cooperation, please contact the organizing committee: Tel: 177 2112 0767 (same as WeChat) E-mail: vaccon@bmapglobal.
-
The construction of Tailianxi National Biomedical Cluster was launched to help Healthy China land
Time of Update: 2023-01-05
First of all, Taizhou has a unique mechanism of joint construction of China Medical City by ministries and provinces, gathering global well-known enterprises such as Yangzijiang Pharmaceutical, Rico Biotechnology, Nestlé Health, and Shuoshi Biotechnology, and is currently the largest pharmaceutical industrial park with the most complete industrial chain in China, forming leading industries and characteristic industries such as chemical drugs, biological products (vaccines + antibodies, etc.
-
WuXi Biologics successfully held the "Continuous Innovation - Empowering R&D" Summit Forum
Time of Update: 2023-01-05
As one of the important sub-forums of the shared and open section of the "Zhangjiang Life Science International Innovation Summit", this forum attracted more than 100 professionals to share and discuss cutting-edge technologies and insights in the field of biomedicine from different perspectives, and jointly explore how to use appropriate business models to solve R&D challenges and accelerate drug innovation.
-
More protection Surface brightness ≠ surface roughness!
Time of Update: 2023-01-05
Other food-grade stainless steel pipes mostly use atmospheric solid solution + pickling passivation, or simply no solid solution treatment, need to be thrown by a cloth turbine (usually using polishing paste containing animal fat), so as to obtain a better surface bright effect.
-
TUV Rheinland successfully held an online forum on green and high-quality development of the automotive industry value chain
Time of Update: 2023-01-01
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Sequential Biotech once again obtained ISO15189 international certification for quality and competence requirements of medical laboratories with zero defects
Time of Update: 2023-01-01
62em; font-family:"Arial"; color:black; margin:0in; } SHANGHAI, Dec. 6, 2022 /PRNewswire/ -- Later, Zhizhenda Biolabs once again passed the ISO15189 International Certification for Quality and Competence Requirements for Medical Laboratories issued by the American Association for Laboratory Accreditation (A2LA) with zero defects.
-
The next generation of mitochondrial imaging tools in living and fixed cells – the MitoBrilliant fluorescent probe
Time of Update: 2023-01-01
Fluorescent probes enable high-precision, sensitive, specific, and long-lasting labeling of mitochondria and are critical for a range of demanding scientific and biomedical applications such as high-content screening, flow cytometry, and super-resolution microscopy.
